Biden's Prostate Cancer Diagnosis: Symptoms and Expert Insights
Biden's Prostate Cancer Diagnosis: Early Symptoms and Bone Metastasis
Former U.S. President Biden was diagnosed with 'aggressive' prostate cancer on May 19, 2025, just four months after leaving office, with bone metastasis confirmed. Prostate cancer is the fastest-growing type of male cancer, often showing few early symptoms, making regular screenings essential.

Biden's Diagnosis Date and Cancer Aggressiveness
According to BBC and News1 reports on May 19, 2025, Biden was diagnosed with prostate cancer four months after his presidency ended, with bone metastasis confirmed. The cancer was rated at a severity level of 9, the highest risk category for prostate cancer.
Bone Metastasis and Survival Rates
When prostate cancer spreads to bones, active treatment can achieve a five-year survival rate of up to 49%. This demonstrates that even with high-risk cancer, effective treatment is possible. However, without early diagnosis, achieving such survival rates remains challenging, underscoring the importance of regular check-ups. Recent medical advancements include targeted therapies for bone metastasis, offering hope for improved survival rates in the future.
Prostate Cancer Symptoms: Similar to Enlarged Prostate
Early symptoms of prostate cancer closely resemble those of benign prostatic hyperplasia (BPH), including difficulty urinating, frequent urination, and urinary tract infections. However, most cases progress without noticeable symptoms, making regular screenings crucial. Biden’s case appears to have involved late detection due to the absence of early symptoms. While BPH and prostate cancer share similar symptoms, accurate diagnosis requires blood tests and ultrasound.
Prostate Cancer Excluded from National Screening Programs
Prostate cancer ranks as the second most common male cancer, with increasing annual cases, yet it is excluded from national cancer screening programs. This exclusion likely stems from cost and testing accuracy concerns. Men over 50 are advised to undergo annual prostate screenings (PSA tests) at urology clinics. Recent medical discussions focus on including prostate cancer in national screening initiatives to improve early detection rates.
Diagnosis and Treatment Process for Prostate Cancer
Biden was diagnosed with aggressive prostate cancer, confirmed with bone metastasis, prompting immediate active treatment. Early-stage prostate cancer often allows for cure through surgery or radiation therapy, but bone metastasis typically requires hormone therapy and chemotherapy. Biden is undergoing these treatments to improve his survival outlook. Medical research continues to develop new drugs targeting bone metastasis patients, expanding future treatment options.
Experts' Recommendation for Early Screening
Due to its asymptomatic nature, prostate cancer necessitates annual screenings for men over 50. The PSA blood test is a simple and accessible method performed at urology clinics. Since it is excluded from national screening programs, personal regular check-ups are essential. Medical experts recommend combining PSA tests with workplace health programs to increase early detection rates.
The Importance of Early Detection
Biden's case reemphasizes the critical importance of early prostate cancer detection. If diagnosed before bone metastasis occurs, surgery or radiation therapy offers high cure potential. Once bone metastasis is confirmed, treatment focuses on slowing progression through medication and hormone therapy. Recent studies show a five-year survival rate above 90% for early-stage cases versus 49% for those with bone metastasis, highlighting the significance of timely diagnosis.
Expert Response and Safety Information
Experts recommend annual PSA tests for men over 50 to detect prostate cancer early. They also stress that because symptoms resemble BPH, accurate diagnosis requires blood tests and ultrasound. Late detection, as seen in Biden’s case, can lead to bone metastasis, complicating treatment. Medical campaigns aim to improve public awareness of prostate cancer, encouraging higher participation in early screenings.
Key Information: Prostate Cancer Screening Methods
Prostate cancer is diagnosed through a blood test measuring PSA (prostate-specific antigen) levels. Men over 50 should consider further evaluation if PSA exceeds 4 ng/mL. This method remains central to early detection, with recent advancements combining PSA tests and high-precision ultrasound for improved accuracy.
FAQ: Questions About Biden's Cancer Diagnosis
Has Biden's prostate cancer spread to the bones?
Yes, bone metastasis was confirmed in reports dated May 19, 2025.
FAQ: How is Prostate Cancer Aggressiveness Rated?
The cancer severity rating of 9 indicates it is classified as 'aggressive,' the highest risk level for prostate cancer.
FAQ: Why Is Prostate Cancer Excluded from National Screening Programs?
Prostate cancer is excluded due to cost and accuracy concerns in testing. Therefore, men over 50 are advised to undergo personal regular screenings.
Conclusion: Early Detection Determines Survival Rates
Biden's case underscores the critical role of early prostate cancer detection. Diagnosing before bone metastasis allows for higher cure rates through surgery or radiation therapy. Men over 50 should make annual PSA tests at urology clinics a standard part of health management. With ongoing medical advancements, diagnosis and treatment methods are becoming more precise, contributing to improved survival rates through early detection.
You can explore similar articles in one place.
View Related ArticlesFAQ
Has Biden's prostate cancer spread to the bones?
Yes, bone metastasis was confirmed in reports dated May 19, 2025.
How is Prostate Cancer Aggressiveness Rated?
The cancer severity rating of 9 indicates it is classified as 'aggressive,' the highest risk level for prostate cancer.
Why Is Prostate Cancer Excluded from National Screening Programs?
Prostate cancer is excluded due to cost and accuracy concerns in testing. Therefore, men over 50 are advised to undergo personal regular screenings.
Korean Source
This article is an English localization of a Korean-language report from BlogScore. Original: 바이든 암 투병 진단 관련 증상, 전문가 해설